Cargando…

Late Campylobacter jejuni mastitis after augmentation mammoplasty

Breast implant-associated infections (BIAI) occur in approximately 2% of patients after augmentation mammoplasty. In some cases, BIAI can be treated conservatively, whereas others need implant removal. Knowledge of uncommon potential pathogens in BIAI is important to ensure optimal treatment of BIAI...

Descripción completa

Detalles Bibliográficos
Autores principales: Vedin, Tomas, Bergenfeldt, Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318823/
https://www.ncbi.nlm.nih.gov/pubmed/34337129
http://dx.doi.org/10.1016/j.jpra.2021.06.004
_version_ 1783730325477654528
author Vedin, Tomas
Bergenfeldt, Henrik
author_facet Vedin, Tomas
Bergenfeldt, Henrik
author_sort Vedin, Tomas
collection PubMed
description Breast implant-associated infections (BIAI) occur in approximately 2% of patients after augmentation mammoplasty. In some cases, BIAI can be treated conservatively, whereas others need implant removal. Knowledge of uncommon potential pathogens in BIAI is important to ensure optimal treatment of BIAI. In the present case report, we describe a case of bilateral late Campylobacter jejuni mastitis in a 34-year-old woman without previous symptoms of gastroenteritis. While Staphylococci are common causative pathogens in BIAI, there are numerous potential pathogens. This case highlights the importance of careful consideration of antibiotic treatment and switch to broad-spectrum antibiotic regimen in BIAI not responding to initial treatment.
format Online
Article
Text
id pubmed-8318823
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83188232021-07-31 Late Campylobacter jejuni mastitis after augmentation mammoplasty Vedin, Tomas Bergenfeldt, Henrik JPRAS Open Case Report Breast implant-associated infections (BIAI) occur in approximately 2% of patients after augmentation mammoplasty. In some cases, BIAI can be treated conservatively, whereas others need implant removal. Knowledge of uncommon potential pathogens in BIAI is important to ensure optimal treatment of BIAI. In the present case report, we describe a case of bilateral late Campylobacter jejuni mastitis in a 34-year-old woman without previous symptoms of gastroenteritis. While Staphylococci are common causative pathogens in BIAI, there are numerous potential pathogens. This case highlights the importance of careful consideration of antibiotic treatment and switch to broad-spectrum antibiotic regimen in BIAI not responding to initial treatment. Elsevier 2021-06-18 /pmc/articles/PMC8318823/ /pubmed/34337129 http://dx.doi.org/10.1016/j.jpra.2021.06.004 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Vedin, Tomas
Bergenfeldt, Henrik
Late Campylobacter jejuni mastitis after augmentation mammoplasty
title Late Campylobacter jejuni mastitis after augmentation mammoplasty
title_full Late Campylobacter jejuni mastitis after augmentation mammoplasty
title_fullStr Late Campylobacter jejuni mastitis after augmentation mammoplasty
title_full_unstemmed Late Campylobacter jejuni mastitis after augmentation mammoplasty
title_short Late Campylobacter jejuni mastitis after augmentation mammoplasty
title_sort late campylobacter jejuni mastitis after augmentation mammoplasty
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318823/
https://www.ncbi.nlm.nih.gov/pubmed/34337129
http://dx.doi.org/10.1016/j.jpra.2021.06.004
work_keys_str_mv AT vedintomas latecampylobacterjejunimastitisafteraugmentationmammoplasty
AT bergenfeldthenrik latecampylobacterjejunimastitisafteraugmentationmammoplasty